[Form 4] Shore Bancshares Inc Insider Trading Activity

Rhea-AI Filing Summary

Marvell Technology, Inc. (MRVL) – Form 144 filing overview

The filing discloses a proposed sale of 78,209 common shares of Marvell Technology, Inc. through Northern Trust Securities Inc. on or about 07 / 02 / 2025. The aggregate market value of the planned transaction is $5.47 million, based on the market price at the time of the notice. Relative to Marvell’s ~862.2 million shares outstanding, the sale represents roughly 0.009 % of total common shares, indicating a limited dilution or market-supply effect.

The securities being sold were acquired between 2016-2025 as non-cash compensation for services rendered. No prior sales have been reported by the filer in the last three months, and the filer certifies that they possess no undisclosed material adverse information about the company.

Key details

• Form type: 144 – Notice of Proposed Sale under Rule 144
• Broker: Northern Trust Securities Inc., Phoenix, AZ
• Class: Common shares listed on NASDAQ
• Aggregate value: $5.47 million
• Shares outstanding: ~862.2 million
• Relationship to issuer: Not specified (shares earned as compensation)

The filing is procedural and signals a forthcoming insider transaction but does not provide operational or financial performance data. Given the small proportion of shares relative to float, the market impact is expected to be limited unless accompanied by further insider activity or negative news flow.

Positive

• None.

Negative

• Insider intends to sell $5.47 million of shares, which can be perceived negatively if viewed as lack of confidence, though the amount is small.

Insights

Securities Analyst

TL;DR: Small insider sale (0.009 % float) – limited standalone impact, but adds to insider-selling data points.

This Form 144 covers the planned sale of 78,209 MRVL shares worth $5.47 million. The shares stem from equity compensation earned 2016-2025, suggesting routine monetisation rather than a strategic divestiture. Given Marvell’s large float, the sale is statistically immaterial; however, persistent insider selling can weigh on sentiment if it coincides with weaker fundamentals. Investors should monitor subsequent Form 4 filings to confirm execution and watch for clustering of insider disposals.

Corporate Governance Expert

TL;DR: Procedural Rule 144 notice; negligible governance implications absent pattern of sales.

The filer affirms no undisclosed adverse information, satisfying Rule 144 representations. The absence of prior three-month sales and the modest transaction size mitigate governance concerns. Nonetheless, boards often review insider trading windows and 10b5-1 plans to ensure alignment with shareholder interests; investors may wish to verify whether this sale is pursuant to a pre-set trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke James M

(Last) (First) (Middle)

18 E DOVER STREET

(Street)

EASTON MD 21601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHORE BANCSHARES INC [ SHBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		M		6,705	A	(1)	83,887	D
Common Stock								2,374	I	By IRA
Common Stock								5,708	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	07/01/2025		M			6,705	(3)	(4)	Common Stock	6,705	$0	33,036	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Each restricted stock unit represents a contingent right to receive one share of SHBI common stock.

3. Restricted stock units vested July 1, 2025.

4. The restricted stock units vest as follows: 1,565 on March 6, 2026, 4,695 on March 6, 2026, 4,679 units on March 7, 2026, 4,679 units on March 7, 2027, 5,806 units on February 27, 2026, 5,806 units on February 27, 2027 and 5,806 units on February 27, 2028.

Remarks:

	/s/ Christy Lombardi, Attorney in Fact for James M. Burke	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Marvell Technology (MRVL) shares are being sold under this Form 144?

The notice covers 78,209 common shares.

What is the dollar value of the proposed MRVL share sale?

The aggregate market value disclosed is $5.47 million.

When is the approximate sale date for the MRVL shares?

The filer targets July 2, 2025 as the sale date.

What percentage of Marvell’s outstanding shares does this sale represent?

Approximately 0.009 % of the company’s ~862.2 million shares outstanding.

Were these MRVL shares purchased or earned as compensation?

All shares were received as compensation for services rendered between 2016 and 2025.